Wachtell, Lipton, Rosen & Katz advised Aramark on the deal. Aramark (NYSE: ARMK) announced its plan to separate Aramark Uniform Services (AUS) into an independent, publicly...
Aramark’s Separation of Aramark Uniform Services
Bausch + Lomb’s Agreement With Carl C. Icahn
Wachtell, Lipton, Rosen & Katz represented Bausch + Lomb. Bausch + Lomb Corporation entered into an agreement with Carl C. Icahn relating to the composition of...
Evergreen- and Brookfield-Led Consortium’s $16 Billion Acquisition of Nielsen
Wachtell, Lipton, Rosen & Katz, Clifford Chance LLP, DLA Piper, and Baker McKenzie represented Nielsen. Gibson, Dunn & Crutcher LLP and Herbert Smith Freehills LLP represented...
Standard General’s $5.4 Billion Acquisition of TEGNA
Wachtell Lipton Rosen & Katz and Covington & Burling represented TEGNA. KG , Fried Frank Harris Shriver & Jacobson and Pillsbury Winthrop Shaw Pittman represented Standard...
NextGen Healthcare’s Proxy Contest
Wachtell, Lipton, Rosen & Katz represented NextGen Healthcare. NextGen Healthcare, Inc. (Nasdaq: NXGN) held its 2021 Annual Meeting, with its largest shareholder, Sheldon Razin, running a...
CVC Capital Partners’ Acquisition of CFGI
Nelson Mullins Riley & Scarborough represented CFGI, Wachtell, Lipton, Rosen & Katz represented Carlyle, Weil, Gotshal & Manges represented CVC in the transaction. The Carlyle Group...
Cargill and Continental Grain Company’s Acquisition of Sanderson Farms
Freshfields Bruckhaus Deringer (US) acted as legal counsel, and Gibson Dunn & Crutcher acted as tax counsel to Cargill. Wachtell, Lipton, Rosen & Katz and Fishman...
Roivant Sciences’ $200 Million Investment in Immunovant
Wachtell, Lipton, Rosen & Katz served as legal advisor to the special committee of the Immunovant board. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused...
Authentic Brands Group’s $220 Million Acquisition of PVH’s Heritage Brands Business
Wachtell, Lipton, Rosen & Katz represented PVH in the transaction, while Paul, Weiss advised Authentic Brands Group. PVH Corp. [NYSE:PVH] has entered into a definitive agreement to...
MorphoSys’ $1.7 Billion Acquisition of Constellation Pharmaceuticals
Wachtell, Lipton, Rosen & Katz and Willkie Farr & Gallagher advised Constellation on the deal. Goodwin Procter, Dechert and Maiwald acted as legal advisors to Royalty...